The storied success of sildenafil has undeniably influenced the pharmaceutical landscape. However, investing in companies heavily reliant on copycat drugs and the diminishing patent exclusivity https://adrianairem069240.blogchaat.com/41286484/the-blue-pill-and-drugmakers-a-risky-investment